Merck Ventures

“The investments of Merck Ventures will be aligned with the strategic interests of Merck, though formally separated by a ‘Chinese Wall’. With our infrastructure of a leading science technology company we provide start-ups with the support they need to make their vision a commercial success.”

Roel Bulthuis
Senior Vice President and Managing Director of Merck Ventures

More

2016/06/08

Merck Expands its Investment Fund Merck Ventures

Darmstadt, Germany, June 8, 2016 – Merck, a leading science and technology company, today announced an increased commitment to its corporate venture fund under the new Merck Ventures roof. Four dedicated investment teams will focus on Healthcare, Life Science, Performance Materials and new businesses. The total volume of the newly set-up corporate venture fund of Merck is € 300 million, doubling the volume of the previous biopharma venture fund of € 150 million.

more

Upcomming Events

2016/09/27

Biotech in Europe Investor Forum 2016

16th Annual Biotech in Europe Forum for
Global Partnering & Investment
Congress Center Basel, Switzerland

all upcoming events

Funding early Innovation

We invest in early stage companies that develop the next generation products, technologies and applications to serve unmet medical needs and improve patient outcomes, as well as new solutions for science driven innovation.

More

Innovative Science.
Strategic Insights.

We invest in innovation to develop novel technologies and products to better serve future healthcare needs, solutions and services for R&D and production of drug therapies, as well as high tech chemicals for sophisticated applications.

More

Strategic Venture Capital.

We work closely with our portfolio companies to optimally position their assets towards strategic partnering.

More

Funding early Innovation

We invest in early stage companies that develop the next generation products, technologies and applications to serve unmet medical needs and improve patient outcomes, as well as new solutions for science driven innovation.

More

Innovative Science.
Strategic Insights.

We invest in innovation to develop novel technologies and products to better serve future healthcare needs, solutions and services for R&D and production of drug therapies, as well as high tech chemicals for sophisticated applications.

More

Strategic Venture Capital.

We work closely with our portfolio companies to optimally position their assets towards strategic partnering.

More